Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 4:48 pm Sale | 13G | CYTOSORBENTS CORP CTSO | Granahan Investment Management LLC | 2,094,882 3.850% | -1,523,261 (-42.10%) | View |
2024-02-14 4:42 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 3,051,402 6.870% | 604,313 (+24.70%) | View |
2024-02-14 09:00 am Purchase | 13G | CYTOSORBENTS CORP CTSO | Granahan Investment Management LLC | 3,618,143 6.930% | 3,618,143 (New Position) | View |
2024-01-08 3:00 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 3,254,213 7.300% | 712,122 (+28.01%) | View |
2023-02-14 1:08 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,447,089 5.610% | 259,307 (+11.85%) | View |
2023-02-09 11:16 am Sale | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 1,956,828 4.480% | -252,337 (-11.42%) | View |
2023-02-07 2:28 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 2,542,091 5.800% | 2,542,091 (New Position) | View |
2022-08-11 08:39 am Purchase | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,187,782 5.020% | 30,949 (+1.43%) | View |
2022-07-08 4:57 pm Sale | 13G | CYTOSORBENTS CORP CTSO | BlackRock Inc. BLK | 744,958 1.700% | -1,886,252 (-71.69%) | View |
2022-06-27 5:34 pm Sale | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,156,833 4.950% | -20,313 (-0.93%) | View |
2022-04-22 5:34 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,177,146 5.000% | 89,075 (+4.27%) | View |
2022-02-09 3:43 pm Sale | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 2,209,165 5.080% | -12,441 (-0.56%) | View |
2022-02-02 7:11 pm Sale | 13G | CYTOSORBENTS CORP CTSO | BlackRock Inc. BLK | 2,631,210 6.100% | -131,078 (-4.75%) | View |
2022-01-07 5:10 pm Sale | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,088,071 4.800% | -156,264 (-6.96%) | View |
2021-12-13 5:01 pm Purchase | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 2,244,335 5.160% | 2,244,335 (New Position) | View |
2021-02-10 10:46 am Purchase | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 2,221,606 5.150% | 2,221,606 (New Position) | View |
2021-01-29 09:56 am Purchase | 13G | CYTOSORBENTS CORP CTSO | BlackRock Inc. BLK | 2,762,288 6.400% | 702,686 (+34.12%) | View |
2020-02-05 11:45 am Purchase | 13G | CYTOSORBENTS CORP CTSO | BlackRock Inc. BLK | 2,059,602 6.400% | 73,962 (+3.72%) | View |